A microbiome meta-transcriptomics pipeline identifies a novel human neutrophil elastase inhibitor that protects the colonic epithelial barrier
Stojkovic, B.; Bekkers, M.; Violi, J.; Neilan, B.; Keely, S.; Donald, W. A.; Riveros, C.; Kaiko, G.
Show abstract
Inflammatory Bowel Diseases (IBD) are lifelong conditions. Current therapeutic approaches target inflammatory signalling rather than improving barrier permeability or repair. The gut microbiome provides an exciting opportunity for novel drug discovery to leverage its role in healthy gut homeostasis. There is a clear need to identify bioactive molecules within the microbiota that could protect the intestinal barrier. Our group has developed a systematic pipeline using metatranscriptomic data to identify, produce, purify, and test microbial proteins in IBD, pinpointing multiple novel microbiota-derived proteins linked to disease activity. We identified a new microbiota protein (BMG-1), that specifically inhibits human neutrophil elastase, a pathogenic protease in IBD. This protease inhibition allows protection of the intestinal epithelial barrier from permeability and promotes epithelial healing. BMG-1 also reduces colon damage in a mouse model of colitis. These findings demonstrate the gut microbiota can specifically regulate the balance of protease/anti-protease activity in the colon, and this represents a novel therapeutic strategy for IBD.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease 97%
- Enhancing Recovery from Gut Microbiome Dysbiosis and Alleviating DSS-Induced Colitis in Mice with a Consortium of Rare Short-Chain Fatty Acid-Producing Bacteria 96%
- Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potential 95%
Similar papers in this journal
- Biosynthetic Enzyme-guided Disease Correlation Connects Gut Microbial Metabolites Sulfonolipids to Inflammatory Bowel Disease Involving TLR4 Signaling 97%
- Sprouty2 limits intestinal tuft and goblet cell numbers through GSK3β-mediated restriction of epithelial IL-33. 96%
- Multiomic analysis reveals cellular and epigenetic plasticity in intestinal pouches of ulcerative colitis patients 96%
Similar papers in this journal
- Immune signaling mediates stromal changes to support epithelial reprogramming in Celiac duodenum 95%
- An iPSC-derived small intestine-on-chip with self-organizing epithelial, mesenchymal and neural cells 95%
- Differential translocation of bacteriophages across the intestinal barrier in health and Crohn's disease 94%
Similar papers in this journal
- A hepatocyte-specific transcriptional program driven by Rela and Stat3 exacerbates experimental colitis in mice by modulating bile synthesis 96%
- Peptidoglycan-Chi3l1 interaction shapes gut microbiota in intestinal mucus layer 95%
- Sex-dependent gastrointestinal colonization resistance to MRSA is microbiota and Th17 dependent 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.